Search MDNC
Medinotec Inc.
OTC · CIK 1931055
Last close5
Daily change+0.00 (0.00%)
10 Years gain+0.00%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
MDNC · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 0228
Fundamental
72.5Momentum
25.2Acceleration
15.1Confidence
75.0Annual Revenue5
Quarterly Revenue15
Annual CFO5
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth21.1 / 25
Quality12.8 / 25
Capital Efficiency20.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 8.9544 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Warnings
Receivables anomaly · MEDIUMAccounts receivable growth is materially above revenue growth.
Operating margin compression · MEDIUMOperating margin compressed by 4.9667 percentage points.
ROIC declining · MEDIUMROIC declined by 36.3525 percentage points.
Possible growth trap · HIGHRevenue growth is high, but quality indicators are deteriorating.
Key Metrics
Revenue Growth TTM38.5%OK
Revenue CAGR 3Y113.51%OK
Gross Margin52.75%OK
Operating Margin14.58%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC39.49%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 FY Feb 28, 2026 | $9.73M | $5.13M | $1.09M | $906,798.00 | $905,435.00 | 52.71% | 11.25% | 9.31% | 36.51% | n/a |
| 2026 FY Feb 28, 2025 | $9.11M | $4.82M | $3.19M | $877,834.00 | $788,821.00 | 52.87% | 35.02% | 8.66% | 530.36% | n/a |
| 2025 FY Feb 29, 2024 | $5.02M | $2.44M | $600,578.00 | $14,242.00 | $11,987.00 | 48.65% | 11.96% | 0.24% | n/a | n/a |
| 2024 FY Feb 28, 2023 | $999,579.00 | $581,822.00 | -$238,587.00 | -$490,549.00 | -$545,826.00 | 58.21% | -23.87% | -54.61% | n/a | n/a |
| 2023 FY Feb 28, 2022 | $1.04M | $455,154.00 | -$190,616.00 | -$137,013.00 | -$227,569.00 | 43.75% | -18.32% | -21.88% | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $10.56M | sum latest 4 fiscal quarters Revenue | OK | 0001663577-26-000202, 0001663577-25-000293 |
| Revenue Growth TTM | 38.5% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001663577-26-000202, 0001663577-25-000293 |
| Revenue CAGR 3Y | 113.51% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001663577-26-000175 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001663577-26-000175 |
| Gross Profit CAGR 3Y | 106.56% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001663577-26-000175 |
| Operating Income Growth | 3.31% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001663577-26-000202, 0001663577-25-000293 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 52.75% | Gross Profit / Revenue | OK | 0001663577-26-000202, 0001663577-25-000293 |
| Operating Margin | 14.58% | Operating Income / Revenue | OK | 0001663577-26-000202, 0001663577-25-000293 |
| ROIC | 39.49% | NOPAT / Average Invested Capital | OK | 0001663577-26-000202, 0001663577-25-000293 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001663577-26-000202 |
| Interest Coverage | 17.86x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 5.81x | Current Assets / Current Liabilities | OK | derived |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |